The Center for iPS Cell Research and Application (CiRA) publishes a quarterly newsletter in which our members contribute an essay on current bioethical issues for readers unfamiliar with the field.
Click here for the CiRA Reporter page
How to consider an unproven therapy
CiRA Reporter Vol.30
April 21, 2022
With the coronavirus pandemic, you may have seen the term ‘unproven/unapproved’ more often in news reports about therapeutic drugs and vaccines. However, we may need to consider what exactly ‘unproven/unapproved’ treatment means.
Using surveys to connect science and society
CiRA Reporter Vol.29
January 31, 2022
Science and society have always had an essential relationship, and with science advancing at a more rapid pace, the need and opportunity for dialogue between the two has increased.
CiRA Reporter Vol.28
October 21, 2021
The COVID-19 pandemic has shown how much discord there is in the public about science. Disagreements about masks, social distancing and vaccines have led to massive protests and even violence. Yet a recent global survey by 3M found that people's confidence in science has actually improved compared to before the pandemic.
Relaxing the 14-day rule
CiRA Reporter Vol.27
July 29, 2021
This past May, the International Society for Stem Cell Research (ISSCR) revised its guidelines for the first time in five years. Among the changes was a relaxation of the “14-day rule,” which prohibits a human embryo from being cultured past 14 days.
CiRA Reporter Vol.26
April 30, 2021
At least once every year, the Uehiro Research Division for iPS Cell Ethics visits junior high schools to directly teach students about iPS cells. (Since the COVID-19 pandemic, we have been conducting these events remotely.) These programs include lessons on the basic science, but they also include discussions on relevant ethical issues.
Peer-review and the COVID-19 Pandemic
CiRA Reporter Vol.25
January 29, 2021
The publication of peer-reviewed papers is the primary way through which scientists publicly share their research findings. Before this happens, other experts will review the paper and decide whether the paper should be published (i.e. peer review).
The Fashion of Ethics
CiRA Reporter Vol.24
October 29, 2020
In one of his books, the philosopher Kiyokazu Washida introduces the new potentials or implications of words. For example, he writes about the Japanese word “sara,” which roughly means “new” in English.
Corona Virus and Regenerative Medicine
CiRA Reporter Vol.23
July 31, 2020
The pandemic caused by the coronavirus disease 2019 (COVID-19) has caused changes to daily lives throughout the world. These changes have led to an urgency for new drugs and vaccines.
Patient and Public Involvement (PPI)
CiRA Reporter Vol.22
April 30, 2020
A new initiative is giving greater consideration to patient experiences and opinions in future medical treatments.
The History of Informed Consent
CiRA Reporter Vol.21
January 30, 2020
For new drugs and medical treatments to reach the market, they must be first tested for their safety and efficacy on a number of human volunteers in clinical trials. To perform the trials, the participating doctors and researchers must adequately explain to the volunteers the purpose and risk of the trial and receive agreement from the volunteers.